세포 동결 보존 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global cell cryopreservation market size is expected to reach USD 11.42 Billion in 2034 from USD 4.26 Billion in 2025, growing at a CAGR of 11.58% during 2026-2034.The Cell Cryopreservation market is poised for significant growth, driven by the increasing demand for cell-based therapies, regenerative medicine, and advancements in biobanking technologies. Cryopreservation, the process of cooling and storing cells at very low temperatures to halt biological activity, is essential for preserving the viability and functionality of various cell types, including stem cells, immune cells, and reproductive cells. As the global focus on personalized medicine and innovative therapeutic approaches intensifies, the need for effective cryopreservation techniques is becoming increasingly critical. This market encompasses a wide range of products and services, including cryopreservation equipment, cryoprotectants, and storage solutions, all designed to ensure the integrity of biological samples over extended periods.

Technological advancements are significantly shaping the Cell Cryopreservation market, with innovations in cryopreservation methods and equipment enhancing the efficiency and reliability of the process. The development of automated cryopreservation systems and advanced monitoring technologies is improving the precision of temperature control and reducing the risk of ice crystal formation, which can compromise cell viability. Additionally, the integration of artificial intelligence and data analytics in cryopreservation protocols is enabling researchers and clinicians to optimize storage conditions and predict cell behavior post-thaw. As the market continues to evolve, companies that prioritize research and development to enhance their cryopreservation solutions will likely capture a larger share of the growing demand.

Moreover, the Cell Cryopreservation market is increasingly influenced by regulatory frameworks and ethical considerations surrounding the use of human cells and tissues. As biobanks and research institutions strive to comply with stringent regulations, the demand for standardized and validated cryopreservation protocols will continue to rise. This trend is driving investment in training and certification programs for personnel involved in cell handling and storage, ensuring that best practices are followed. Furthermore, the growing emphasis on sustainability and environmental responsibility in the life sciences sector is prompting companies to explore eco-friendly cryopreservation solutions. As the focus on cell-based therapies and regenerative medicine expands, the need for reliable and efficient cryopreservation methods will be paramount, positioning companies that align their offerings with industry needs for success in this dynamic market.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

• Cryopreservation Media Agent(Ethylene Glycol, Dimethyl Sulfoxide, Glycerol, Others)
• Equipment Type(Freezers, Liquid Nitrogen Supply Tanks, Others)

By Application

• Stem Cells
• Oocytes Cells
• Sperm Cells
• Others

By End User

• Pharmaceutical And Biotechnology Company
• Research Institute
• Others

COMPANIES PROFILED

• PromoCell GmbH, BioLife Solutions Inc., HiMedia Laboratories, Merck Group KGaA, Lonza, Thermo Fisher Scientific Inc., Eppendorf Corporate, Sartorius AG, Creative Biolabs, Danaher Corporation

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CELL CRYOPRESERVATION MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Cryopreservation Media Agent(Ethylene Glycol, Dimethyl Sulfoxide, Glycerol, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Equipment Type(Freezers, Liquid Nitrogen Supply Tanks, Others) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CELL CRYOPRESERVATION MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Stem Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Oocytes Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Sperm Cells Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CELL CRYOPRESERVATION MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Pharmaceutical And Biotechnology Company Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Research Institute Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CELL CRYOPRESERVATION MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CELL CRYOPRESERVATION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 PromoCell GmbH
  • 9.2.2 BioLife Solutions Inc
  • 9.2.3 HiMedia Laboratories
  • 9.2.4 Merck Group KGaA
  • 9.2.5 Lonza
  • 9.2.6 Thermo Fisher Scientific Inc
  • 9.2.7 Eppendorf Corporate
  • 9.2.8 Sartorius AG
  • 9.2.9 Creative Biolabs
  • 9.2.10 Danaher Corporation